J Pekka Nuorti

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies
    Peter Klemets
    National Public Health Institute KTL, Department of Infectious Disease Epidemiology and Control, Helsinki, Finland
    BMC Infect Dis 8:96. 2008
  2. ncbi Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts
    J Pekka Nuorti
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Prev Med 34:46-53. 2008
  3. ncbi Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009
    Peng Jun Lu
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mail Stop A 19, Atlanta, GA 30333, USA
    Am J Epidemiol 175:827-37. 2012
  4. ncbi Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004
    Fangjun Zhou
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop E 52, Atlanta, GA 30333, USA
    Pediatrics 121:253-60. 2008
  5. ncbi Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)
    J Pekka Nuorti
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Atlanta GA 30333, USA
    MMWR Recomm Rep 59:1-18. 2010
  6. ncbi Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008
    Peng Jun Lu
    Assessment Branch, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia 30333, USA
    Am J Prev Med 39:287-95. 2010
  7. ncbi Effect of vaccine shortages on timeliness of pneumococcal conjugate vaccination: results from the 2001-2005 National Immunization Survey
    Philip J Smith
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, National Immunization Program, MS E 32, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA
    Pediatrics 120:e1165-73. 2007
  8. ncbi International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005
    Michael G Bruce
    Arctic Investigations Program, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Circle Drive, Anchorage, AK 99508, USA
    Emerg Infect Dis 14:25-33. 2008
  9. ncbi Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States
    Fangjun Zhou
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop E 52, Atlanta, GA 30333, USA
    Arch Pediatr Adolesc Med 161:1162-8. 2007
  10. ncbi Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States
    Chiaojung Jillian Tsai
    Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37212, USA
    Clin Infect Dis 46:1664-72. 2008

Collaborators

Detail Information

Publications18

  1. ncbi Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies
    Peter Klemets
    National Public Health Institute KTL, Department of Infectious Disease Epidemiology and Control, Helsinki, Finland
    BMC Infect Dis 8:96. 2008
    ..We evaluated the risk and mortality from invasive pneumococcal disease (IPD) among persons with and without the underlying medical conditions which are considered PPV23 indications...
  2. ncbi Uptake of pneumococcal conjugate vaccine among children in the 1998-2002 United States birth cohorts
    J Pekka Nuorti
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Prev Med 34:46-53. 2008
    ..Age-appropriate PCV7 coverage was estimated and characteristics associated with undervaccination were identified for children in the 1998-2002 birth cohorts...
  3. ncbi Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009
    Peng Jun Lu
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mail Stop A 19, Atlanta, GA 30333, USA
    Am J Epidemiol 175:827-37. 2012
    ..Effective strategies to increase pneumococcal vaccination coverage among at-risk groups are needed...
  4. ncbi Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004
    Fangjun Zhou
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop E 52, Atlanta, GA 30333, USA
    Pediatrics 121:253-60. 2008
    ..The goal was to estimate the population effect of 7-valent pneumococcal conjugate vaccine on rates of acute otitis media-related ambulatory visits and antibiotic prescriptions for <2-year-old children enrolled in private insurance plans...
  5. ncbi Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP)
    J Pekka Nuorti
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Atlanta GA 30333, USA
    MMWR Recomm Rep 59:1-18. 2010
    ..Children aged 2-18 years with underlying medical conditions also should receive PPSV23 after completing all recommended doses of PCV13...
  6. ncbi Pneumococcal polysaccharide vaccination among adults aged 65 years and older, U.S., 1989-2008
    Peng Jun Lu
    Assessment Branch, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia 30333, USA
    Am J Prev Med 39:287-95. 2010
    ..The 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been recommended for all people aged ≥65 years in the U.S. since 1983; consistent surveillance for vaccine coverage has been conducted since 1989...
  7. ncbi Effect of vaccine shortages on timeliness of pneumococcal conjugate vaccination: results from the 2001-2005 National Immunization Survey
    Philip J Smith
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, National Immunization Program, MS E 32, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA
    Pediatrics 120:e1165-73. 2007
    ..We describe the effects of the pneumococcal conjugate vaccine shortages in 2001-2003 and 2004 on the timeliness of vaccination uptake for quarterly birth cohorts affected by the shortages...
  8. ncbi International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005
    Michael G Bruce
    Arctic Investigations Program, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Circle Drive, Anchorage, AK 99508, USA
    Emerg Infect Dis 14:25-33. 2008
    ..IPD rates are high among indigenous persons and children in Arctic countries. After vaccine introduction, IPD caused by non-PCV7 serotypes increased in Alaska...
  9. ncbi Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States
    Fangjun Zhou
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop E 52, Atlanta, GA 30333, USA
    Arch Pediatr Adolesc Med 161:1162-8. 2007
    ..To estimate the effect of 7-valent pneumococcal conjugate vaccine (PCV7) on rates of pneumonia-related health care utilization and costs in children younger than 2 years...
  10. ncbi Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States
    Chiaojung Jillian Tsai
    Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37212, USA
    Clin Infect Dis 46:1664-72. 2008
    ....
  11. ncbi Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine
    Katherine A Poehling
    Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    Pediatrics 119:707-15. 2007
    ..In this study we estimated the effect of routine childhood immunization with heptavalent pneumococcal conjugate vaccine on frequent otitis media (3 episodes in 6 months or 4 episodes in 1 year) and pressure-equalizing tube insertions...
  12. ncbi National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States
    Carlos G Grijalva
    Department of Preventive Medicine, Division of Pharmacoepidemiology, Vanderbilt University School of Medicine, Nashville, TN 37232-2637, USA
    Pediatrics 118:865-73. 2006
    ..Persistence of this trend will produce a significant reduction of the otitis media burden and further enhance the cost-effectiveness of heptavalent pneumococcal conjugate vaccine...
  13. ncbi Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
    Carlos G Grijalva
    Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN 37212, USA
    Lancet 369:1179-86. 2007
    ..We therefore assessed the effect of the programme on rates of all-cause and pneumococcal pneumonia admissions...
  14. ncbi Sindbis virus infection in resident birds, migratory birds, and humans, Finland
    Satu Kurkela
    Department of Virology, Faculty of Medicine, Haartman Institute at the University of Helsinki, Haartmaninkatu 3, Helsinki, Finland
    Emerg Infect Dis 14:41-7. 2008
    ..Among 2,529 persons, the age-standardized seroprevalence (1999-2003) was 5.2%; seroprevalence and incidence (1995-2003) were highest in North Karelia (eastern Finland). Grouse may contribute to the epidemiology of SINV in humans...
  15. ncbi Pitfalls in case-control studies of vaccine effectiveness
    Matthew R Moore
    Clin Infect Dis 45:1241-2; author reply 1242-3. 2007
  16. ncbi A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce
    J Pekka Nuorti
    Department of Infectious Disease Epidemiology, National Public Health Institute, Helsinki, Finland
    J Infect Dis 189:766-74. 2004
    ..In Finland, clinical microbiology laboratories routinely report Y. pseudotuberculosis isolations and submit isolates for serotype analysis. In October 1998, the number of serotype O:3 infections increased markedly...
  17. ncbi Defining the population-based burden of nosocomial pneumococcal bacteremia
    Outi Lyytikainen
    Department of Infectious Disease Epidemiology, National Public Health Institute, Mannerheimintie 166, FIN 00300 Helsinki, Finland
    Arch Intern Med 167:1635-40. 2007
    ..The characteristics, risk factors, and outcome of patients with nosocomial pneumococcal bacteremia (NPB) have not been described in large, population-based studies...
  18. ncbi Invasive group B streptococcal infections in Finland: a population-based study
    Outi Lyytikainen
    National Public Health Institute, Helsinki, Finland
    Emerg Infect Dis 9:469-73. 2003
    ..Establishing national guidelines to prevent perinatal GBS is likely to reduce the incidence of the disease...